HIF1α and HIF2α ChIP in VSMCs
Corresponding Organization :
Other organizations : Ministry of Education of the People's Republic of China, Capital Medical University, University of Michigan–Ann Arbor, Dalian Medical University, First Affiliated Hospital of Dalian Medical University, King's College Hospital, Beijing Anzhen Hospital, National Cancer Institute, National Institutes of Health, Center for Cancer Research
Variable analysis
- Hif1a floxed (Hif1afl/fl) or Hif1a knockout (Hif1aΔSMC) VSMCs
- Angiotensin II (Ang II) treatment (1 μM) for 24 h
- HIF1α and HIF2α binding to DNA, as measured by ChIP assays
- Formaldehyde crosslinking concentration (1%)
- Crosslinking duration (10 min)
- Buffer used for crosslinking (1× PBS)
- Positive control: Antibodies used for ChIP assays (HIF1α and HIF2α)
- Negative control: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!